Die diesjährige ATS International Conference findet vom 15. bis 20. Mai 2026 in Orlando, Florida (USA), statt. An den ersten beiden Tagen wird der Respiratory Innovation Summit (RIS) als Vorkonferenz zur ATS veranstaltet.
Vorkonferenz RIS: 15.–16. Mai
Internationale Konferenz: 17.–20. Mai
Wir freuen uns sehr darauf, Sie in Orlando zu treffen. Melden Sie sich gerne vorab bei uns, um einen Termin zu vereinbaren.
Postgraduate Course
PG21 Translational Windows into the Lung Microenvironment: Advances with Precision-cut Lung Slices
How to Get PCLS if You Cannot Make Them Yourself
Saturday, May 16, 2026, 12:50 PM – 1:05 PM (EDT)
Speaker: Armin Braun
Mini-Symposium
B19 Emerging Therapeutic Strategies for Fibrotic Lung Disease
Telomerase ModRNA Therapy Attenuates Senescence and Fibrosis in Human Precision-Cut Lung Slices (PCLS)
Monday, May 18, 2026, 10:15 AM – 10:27 AM
Speaker: Christina Hesse
Orlando, Florida (USA)
15. Mai 2026 - 20. Mai 2026
Englisch
(Poster Board # P95) Dissecting Early Fibro-inflammatory Pathways in Human Lung Tissue Ex Vivo
(Poster Board # P105) Dupilumab Attenuates Rhinovirus-induced Exacerbation of an Asthma-like Phenotype in Human Precision-cut Lung Slices
(Poster Board # P117) Cryopreservation of Human Precision-cut Lung Slices Using a Rapid Freezing Method
(Poster Board # P166) RNA-interference-based Therapeutics Targeting Fibrosis-associated Genes in Human Lung Tissue
(Poster Board # P183) Arginase 1 Is Associated With the Severity of Idiopathic Pulmonary Fibrosis and Patient Outcome
(Poster Board # 402) The Transcriptome of CD14+CD163-HLA-DRlow Monocytes Predicts Mortality in Idiopathic Pulmonary Fibrosis and Suggests Potential Therapeutic Targets
(Poster Board # 421) Translational Assessment of Inhalable Therapies Using Multi-Model Integration
(Poster Board # 1011) Clonal Hematopoiesis Is Associated With Progression of Idiopathic Pulmonary Fibrosis
(Poster Board # P1803) Sex-specific Phenotypes and Outcomes in Non‑IPF Interstitial Lung Disease: Results From the INSIGHTS-ILD Registry
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin